Historial de ingresos, beneficios y flujo de caja según los estados financieros oficiales.
Agilent Technologies, Inc. ofrece soluciones centradas en aplicaciones para los mercados de ciencias biológicas, diagnóstico y química aplicada en todo el mundo. La empresa opera a través de tres segmentos: mercados de diagnóstico y ciencias biológicas, Agilent CrossLab y mercados aplicados. El segmento de Mercados de Diagnóstico y Ciencias de la Vida ofrece sistemas y componentes de cromatografía líquida; y sistemas de espectrometría de masas de cromatografía líquida.
Traducido automáticamente
Ver gráficos interactivos y estados completos → Modelo de valoración (DCF) →
| Cuenta de resultados | TTM → 2026-07-31 | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 | 2020-10-31 | 2019-10-31 | 2018-10-31 | 2017-10-31 | 2016-10-31 | 2015-10-31 | 2014-10-31 | 2013-10-31 | 2012-10-31 | 2011-10-31 | 2010-10-31 | 2009-10-31 | 2008-10-31 | 2007-10-31 | 2006-10-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos totales | $7.4B | $6.9B | $6.5B | $6.8B | $6.8B | $6.3B | $5.3B | $5.2B | $4.9B | $4.5B | $4.2B | $4.0B | $4.0B | $3.9B | $6.9B | $6.6B | $5.4B | $4.5B | $5.8B | $5.4B | $5.0B |
| Beneficio bruto | $4.0B | $3.6B | $3.5B | $3.5B | $3.7B | $3.4B | $2.8B | $2.8B | $2.7B | $2.4B | $2.2B | $2.0B | $2.0B | $1.9B | $3.6B | $3.5B | $2.9B | $2.3B | $3.2B | $3.0B | $2.7B |
| % de margen bruto | 53.7% | 52.4% | 54.3% | 50.7% | 54.4% | 53.9% | 53.1% | 54.3% | 54.7% | 53.9% | 52.3% | 50.5% | 48.8% | 49.0% | 52.5% | 53.3% | 53.8% | 51.1% | 55.4% | 54.8% | 53.4% |
| Ingresos operativos (EBIT) | $1.6B | $1.5B | $1.5B | $1.4B | $1.6B | $1.3B | $846M | $941M | $904M | $841M | $615M | $522M | $419M | $386M | $1.1B | $1.1B | $566M | $47M | $795M | $584M | $464M |
| % de margen operativo | 22.2% | 21.3% | 22.9% | 19.8% | 23.6% | 21.3% | 15.8% | 18.2% | 18.4% | 18.8% | 14.6% | 12.9% | 10.3% | 9.9% | 16.3% | 16.2% | 10.4% | 1.1% | 13.8% | 10.8% | 9.3% |
| Ingresos netos | $1.4B | $1.3B | $1.3B | $1.2B | $1.3B | $1.2B | $719M | $1.1B | $316M | $684M | $460M | $401M | $549M | $724M | $1.2B | $1.0B | $684M | ($31M) | $693M | $638M | $3.3B |
| % de margen neto | 19.5% | 18.8% | 19.8% | 18.1% | 18.3% | 19.1% | 13.5% | 20.7% | 6.4% | 15.3% | 10.9% | 9.9% | 13.6% | 18.6% | 16.8% | 15.3% | 12.6% | -0.7% | 12.0% | 11.8% | 66.5% |
| EBITDA | $2.0B | $1.8B | $1.9B | $1.7B | $1.9B | $1.8B | $1.2B | $1.2B | $1.2B | $1.1B | $863M | $799M | $723M | $758M | $1.4B | $1.4B | $1.0B | $257M | $1.1B | $775M | $634M |
| Beneficio por acción (EPS) | $5.07 | $4.59 | $4.43 | $4.19 | $4.18 | $3.94 | $2.30 | $3.37 | $0.97 | $2.10 | $1.40 | $1.20 | $1.62 | $2.10 | $3.27 | $2.85 | $1.94 | $-0.09 | $1.87 | $1.57 | $7.50 |
| Acciones en circulación (M) | 283M | 284M | 291M | 296M | 300M | 307M | 312M | 318M | 325M | 326M | 329M | 335M | 338M | 345M | 353M | 355M | 353M | 346M | 371M | 406M | 441M |
Fuente: informes públicos de la empresa (SEC). Verifique en SEC EDGAR antes de confiar en cualquier cifra.
Balances, flujos de caja, datos trimestrales y ratios completos en el visor interactivo de A. /companies/us/A
La información de este sitio es solo educativa e informativa; no constituye asesoramiento de inversión. No se publican precios objetivo ni recomendaciones.
About TickerBase · Data methodology & sources · Privacy · Terms